Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.54M P/E - EPS this Y 74.40% Ern Qtrly Grth -
Income -10.1M Forward P/E -1.00 EPS next Y 53.30% 50D Avg Chg -6.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -76.00%
Dividend N/A Price/Book 0.46 EPS next 5Y - 52W High Chg -96.00%
Recommedations 2.00 Quick Ratio 6.18 Shares Outstanding 1.96M 52W Low Chg 20.00%
Insider Own 0.36% ROA -44.58% Shares Float 1.84M Beta 2.20
Inst Own 7.26% ROE -75.66% Shares Shorted/Prior 23.95K/9.89K Price 0.30
Gross Margin - Profit Margin - Avg. Volume 725,469 Target Price 32.50
Oper. Margin - Earnings Date Aug 12 Volume 119,607 Change -3.88%
About Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension in the United States. The company develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.

Tenax Therapeutics, Inc. News
05/20/24 TENX: First Quarter Results
05/14/24 Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
04/30/24 Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
04/09/24 Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”
04/09/24 TENX: 2023 Financial Results
03/28/24 Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
03/12/24 Tenax Therapeutics to Present at the 36th Annual Roth Conference
02/29/24 Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
02/20/24 Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
02/12/24 TENX: First Patient Enrolled
02/08/24 Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
02/07/24 Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
02/06/24 Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
01/03/24 Breakeven On The Horizon For Tenax Therapeutics, Inc. (NASDAQ:TENX)
12/29/23 Tenax Therapeutics Announces Reverse Stock Split
11/20/23 TENX: IND Clears Way for Phase III
11/17/23 Tenax Therapeutics Announces Professor Javed Butler, M.D., M.P.H, M.B.A., joins PH-HFpEF Scientific Advisory Board
11/13/23 Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), Initiation of Phase 3 sites expected 2023
08/28/23 TENX: Second Quarter Results
08/25/23 7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
TENX Chatroom

User Image peacetrain22 Posted - 2 days ago

$TENX 🚀

User Image LongBallBarn Posted - 1 week ago

$UPC $SYPR $TENX $JAGX

User Image _StockTrader Posted - 1 month ago

Real-Time Stock Data $TENX Price: N/A Volume: 13324 Market Cap: 5835555 PE Ratio: -0.8032345 Powered by: AITX

User Image mudd911 Posted - 1 month ago

$TENX i lost 100k on the amazing stock 😍

User Image RealErnFranklin Posted - 1 month ago

$CHNR im all for it. Send it. But its still dripped .10 each week so not rushing $SNAX im stuggling finding many small caps without combo big red bars, overall. But im lookin $TENX 10% eod sell. Yea these will all pop but idw to be 50% down before they do. Need price stability and uptrend $XRTX may be among a few that pop sooner than later. Selling died. Double bottom. Eyes. Micro float and $5 warrants. Add to watchlist

User Image peacetrain22 Posted - 1 month ago

$TENX this has a history of exploding every now and then. It’s time for that to happen again. Who’s with me?

User Image huntthepermabulls Posted - 1 month ago

$ICPT $TENX $VRAX $GOVX $AEMD bird flu stocks to the moon

User Image badprecog Posted - 1 month ago

$TENX Is the 152 patients that will be recruited for the study large enough to gain approval with one trial if all goes well or do they need 300 for the safety? Thx in advance!

User Image Ibrarex Posted - 05/31/24

$NBY officially in my top 5 worst investments 1 $ICU 2 $TENX 3 $JAGX 4 $ATOS 5 $NBY

User Image enbankmentsandfranklands Posted - 05/28/24

$TENX How many in the US and Globally could the use of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction benefit? Been a long time holder looking to avg down depending on the outlook of this treatment.

User Image enzomassimi Posted - 05/28/24

$TENX

User Image LongBallBarn Posted - 2 months ago

$VTVT $TENX $ATOS

User Image mudd911 Posted - 2 months ago

$TENX im so excited 😍😍😍

User Image Stock_Titan Posted - 2 months ago

$TENX Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update https://www.stocktitan.net/news/TENX/tenax-therapeutics-reports-first-quarter-2024-financial-results-and-7h76lc0wrykt.html

User Image AnicetoGn Posted - 2 months ago

$SINT $CGC $ALUR $INVO $TENX Everybody is looking for the basket of golden eggs, but there has never been such a basket - the idea is to diversify a little bit in everything.

User Image Buttmud Posted - 2 months ago

$TENX warrants out at mid 5 dollar range so expect a drop the day this thing hits that number but def still gonna be big just be prepared

User Image AnicetoGn Posted - 2 months ago

$GWAV $ALUR $TENX $WRAP Some examples of where the bulls are consolidating for this future

User Image jajj3a Posted - 04/30/24

$TENX when is the interim analysis expected? Top line will be around second half of 2025 right?

User Image LongBallBarn Posted - 04/30/24

$MNMD $JAGX $TENX $VTVT

User Image Stocksrunner Posted - 04/30/24

📈 Stocks are buzzing with unusual volume today! Here's what's catching traders' eyes: $WALD GAAP EPS of -$0.99 and revenue of $212.5M are causing a stir. $INTZ PSEG's announcement of first-quarter results and reaffirmed 2024 Non-GAAP Operating Earnings Guidance is drawing attention. $GEHC mixed Q1 results have investors on their toes. $CHGG downgrade and disappointing guidance are impacting its stock. $TENX new US patent is expanding its IP protection. Keep an eye on these movers and shakers as the market unfolds!

User Image Baba200TradeBot Posted - 04/30/24

lowfloatreport.com - Top Low Float stocks as of 04/30/2024 12:30:44 - $CYCC $SBFM $AUUD $TENX $TTOO

User Image Darkpool_1 Posted - 04/30/24

$TENX hitting my scanner.

User Image _www_larval_com_ Posted - 04/30/24

$TENX has soared 8% higher to 13% (~57Kv) in the last few minutes, follow for more volatility.

User Image enzomassimi Posted - 04/30/24

$TENX

User Image Stock_Titan Posted - 04/30/24

$TENX Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) https://www.stocktitan.net/news/TENX/tenax-therapeutics-announces-new-u-s-patent-covering-the-use-of-dyx9o0nz48fx.html

User Image Prospector23 Posted - 04/30/24

$TENX As Warren Buffet says, it’s not the buying or the selling, it’s the waiting…

User Image delrey76 Posted - 04/29/24

$TENX News is starting to spread.

User Image delrey76 Posted - 04/29/24

$TENX Awesome news!!

User Image PatentGrants Posted - 04/29/24

$TENX Tenax Therapeutics will be issued US patent number 11,969,424 tomorrow titled "LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION".

Analyst Ratings
Roth MKM Buy Feb 20, 24